TELA (STOCKS)
TELA Bio, Inc. Common Stock
$0.828600
+0.004200 (+0.51%)
Prev close: $0.824400
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Antony Koblish
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $34.96M
- Employees
- 209
- P/E (TTM)
- -0.93
- P/B (TTM)
- 21.36
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
3
Strong Buy
6
Buy
2
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$-0.19 | $-0.20 | +0.0130 | +6.40% |
|
Jun 2025 (Q2)
|
$-0.22 | $-0.18 | -0.0397 | -22.02% |
|
Mar 2025 (Q1)
|
$-0.25 | $-0.20 | -0.0505 | -25.31% |
|
Dec 2024 (Q4)
|
$-0.23 | $-0.23 | -0.0027 | -1.19% |
Financial Statements
| Revenues | $77.06M |
| Benefits Costs and Expenses | $116.11M |
| Cost Of Revenue | $25.25M |
| Costs And Expenses | $116.11M |
| Gross Profit | $51.81M |
| Nonoperating Income/Loss | -$3.60M |
| Operating Expenses | $87.27M |
| Research and Development | $9.12M |
| Other Operating Expenses | $78.15M |
| Operating Income/Loss | -$35.46M |
| Income/Loss From Continuing Operations After Tax | -$39.00M |
| Income/Loss From Continuing Operations Before Tax | -$39.06M |
| Net Income/Loss | -$39.00M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$39.00M |
| Net Income/Loss Available To Common Stockholders, Basic | -$39.00M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.83 |
| Diluted Earnings Per Share | -$0.83 |
| Basic Average Shares | 94,615,747 |
| Diluted Average Shares | 94,615,747 |
| Assets | $61.59M |
| Current Assets | $56.05M |
| Accounts Receivable | $11.27M |
| Inventory | $11.56M |
| Other Current Assets | $33.22M |
| Noncurrent Assets | $5.54M |
| Fixed Assets | $2.21M |
| Intangible Assets | $1.45M |
| Other Non-current Assets | $1.87M |
| Liabilities | $60.03M |
| Current Liabilities | $16.98M |
| Accounts Payable | $2.37M |
| Wages | $6.76M |
| Other Current Liabilities | $7.84M |
| Noncurrent Liabilities | $43.05M |
| Equity | $1.56M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $1.56M |
| Liabilities And Equity | $61.59M |
| Net Cash Flow From Operating Activities | -$30.88M |
| Net Cash Flow From Operating Activities, Continuing | -$30.88M |
| Net Cash Flow From Investing Activities | $464.00K |
| Net Cash Flow From Investing Activities, Continuing | $464.00K |
| Net Cash Flow From Financing Activities | $42.81M |
| Net Cash Flow From Financing Activities, Continuing | $42.81M |
| Net Cash Flow | $12.40M |
| Net Cash Flow, Continuing | $12.40M |
| Comprehensive Income/Loss | -$39.06M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$39.06M |
| Other Comprehensive Income/Loss | -$18.58M |